Vigil Neuroscience (NASDAQ:VIGL) Lowered to “Hold” Rating by Guggenheim
Guggenheim lowered shares of Vigil Neuroscience (NASDAQ:VIGL – Free Report) from a strong-buy rating to a hold rating in a research report report published on Thursday morning, MarketBeat.com reports. Several other research firms have also recently weighed in on VIGL. Wedbush cut Vigil Neuroscience from a “strong-buy” rating to a “hold” rating and cut their […]
